Cargando…

Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality

The role of neutrophil and lymphocyte counts in blood as prognosis predictors in Community Acquired Pneumonia (CAP) has not been adequately studied. This was a derivation-validation retrospective study in hospitalized patients with CAP and no prior immunosuppression. We evaluated by multivariate ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bermejo-Martin, Jesus F., Cilloniz, Catia, Mendez, Raul, Almansa, Raquel, Gabarrus, Albert, Ceccato, Adrian, Torres, Antoni, Menendez, Rosario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652132/ https://www.ncbi.nlm.nih.gov/pubmed/28958655 http://dx.doi.org/10.1016/j.ebiom.2017.09.023

Ejemplares similares

Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection
por: Bermejo-Martin, Jesús F, et al.
Publicado: (2020)

Effect of Corticosteroids on C-Reactive Protein in Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: The Effect of Lymphopenia
por: Torres, Antoni, et al.
Publicado: (2019)

Lymphocytopenia as a Predictor of Mortality in Patients with ICU-Acquired Pneumonia
por: Ceccato, Adrian, et al.
Publicado: (2019)

Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial
por: Ceccato, Adrian, et al.
Publicado: (2017)

Lymphopenia Is Associated With Poor Outcomes of Patients With Community-Acquired Pneumonia and Sepsis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Simultaneous Depression of Immunological Synapse and Endothelial Injury is Associated with Organ Dysfunction in Community-Acquired Pneumonia
por: Menéndez, Rosario, et al.
Publicado: (2019)

Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2018)

Outcomes of Critically Ill Very Old Patients With Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome
por: Cillóniz, Catia, et al.
Publicado: (2022)

Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2012)

Host-targeted approaches to sepsis due to community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Defining Community-Acquired Pneumonia as a Public Health Threat: Arguments in Favor from Spanish Investigators
por: Cillóniz, Catia, et al.
Publicado: (2020)

Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis
por: Cillóniz, Catia, et al.
Publicado: (2011)

Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients
por: Ferrer, Miquel, et al.
Publicado: (2018)

Risk and Prognostic Factors in Very Old Patients with Sepsis Secondary to Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Cytokine Activation Patterns and Biomarkers Are Influenced by Microorganisms in Community-Acquired Pneumonia
por: Menéndez, Rosario, et al.
Publicado: (2012)

PES Pathogens in Severe Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Antimicrobial Resistance Among Streptococcus pneumoniae
por: Cillóniz, Catia, et al.
Publicado: (2018)

Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging
por: Cillóniz, Catia, et al.
Publicado: (2018)

Predicting treatment failure in patients with community acquired pneumonia: a case-control study
por: Martin-Loeches, Ignacio, et al.
Publicado: (2014)

Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study
por: Menéndez, Rosario, et al.
Publicado: (2023)

Epidemiology, etiology, and risk factors of bacterial pneumonia
por: Torres, Antoni, et al.
Publicado: (2015)

Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2017)

Community-acquired pneumonia in critically ill very old patients: a growing problem
por: Cillóniz, Catia, et al.
Publicado: (2020)

Addendum: Cillóniz, C.; Dominedò, C.; Nicolini, A.; Torres, A. PES Pathogens in Severe Community-Acquired Pneumonia. Microorganisms 2019, 7, 49
por: Cillóniz, Catia, et al.
Publicado: (2019)

The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011–2018
por: Torres, Antoni, et al.
Publicado: (2021)

Steroid therapy and antiviral treatment in SARSCoV-2 pneumonia: clinical contexts and indications
por: Torres, Antoni, et al.
Publicado: (2022)

Ceftaroline in severe community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study
por: Cillóniz, Catia, et al.
Publicado: (2023)

Biomarkers in Community-Acquired Pneumonia (Cardiac and Non-Cardiac)
por: Méndez, Raúl, et al.
Publicado: (2020)

Research in community-acquired pneumonia: the next steps
por: Torres, Antoni, et al.
Publicado: (2017)

Impact of Cefotaxime Non-susceptibility on the Clinical Outcomes of Bacteremic Pneumococcal Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease
por: Estirado, Cristina, et al.
Publicado: (2018)

Ceftobiprole for the treatment of pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Non-lymphopenic pneumocystis pneumonia in low-dose methotrexate therapy: An exception to every rule
por: Lourenço, Jorge, et al.
Publicado: (2020)

Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease
por: Crisafulli, Ernesto, et al.
Publicado: (2020)

IgA level in plasma as a differential factor for influenza infection in severe viral pneumonia
por: Almansa, Raquel, et al.
Publicado: (2014)

RESPONSE OF LYMPHOPENIC PLATELETPHERESIS DONORS TO COVID-19 VACCINATION
por: Bazin, Renee, et al.
Publicado: (2023)

Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational study
por: Motos, Anna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qiqngad0jsjpfma6o0neudqrp6